ArticleMarine drugs2025
Vaterite/Fucoidan Hybrid Microparticles: Fabrication, Loading of Lactoferrin, Structural Characteristics and Functional Properties.
Daniil V Mosievich, Nadezhda G Balabushevich, Pavel I Mishin, Lyubov Y Filatova, Marina A Murina, Olga V Pobeguts, Maria A Galyamina, Ekaterina A Obraztsova, Daria V Grigorieva, Irina V Gorudko and 4 more
Abstract read
In one paragraphArticle in Marine drugs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Daniil V MosievichDepartment of Chemical Enzymology, Faculty of Chemistry, Lomonosov Moscow State University, 1 Leninskiye Gory, 119991 Moscow, Russia.
Nadezhda G BalabushevichDepartment of Chemical Enzymology, Faculty of Chemistry, Lomonosov Moscow State University, 1 Leninskiye Gory, 119991 Moscow, Russia.ORCID 0000-0002-8465-0400 Pavel I MishinDepartment of Chemical Enzymology, Faculty of Chemistry, Lomonosov Moscow State University, 1 Leninskiye Gory, 119991 Moscow, Russia.
Lyubov Y FilatovaDepartment of Chemical Enzymology, Faculty of Chemistry, Lomonosov Moscow State University, 1 Leninskiye Gory, 119991 Moscow, Russia.ORCID 0000-0002-3123-1341 Marina A MurinaLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, 1a Malaya Pirogovskaya str., 119435 Moscow, Russia.
Olga V PobegutsLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, 1a Malaya Pirogovskaya str., 119435 Moscow, Russia.
Maria A GalyaminaLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, 1a Malaya Pirogovskaya str., 119435 Moscow, Russia.
Ekaterina A ObraztsovaLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, 1a Malaya Pirogovskaya str., 119435 Moscow, Russia.ORCID 0000-0002-0086-0970 Daria V GrigorievaDepartment of Biophysics, Belarusian State University, 4 Nezavisimosti Ave., 220030 Minsk, Belarus.ORCID 0000-0003-0210-5474 Irina V GorudkoDepartment of Biophysics, Belarusian State University, 4 Nezavisimosti Ave., 220030 Minsk, Belarus.ORCID 0000-0002-4737-470X Alexey V SokolovSmorodintsev Research Institute of Influenza, 15/17 Prof. Popova Str., 197376 St. Petersburg, Russia.ORCID 0000-0001-9033-0537 Ekaterina V ShmelevaLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, 1a Malaya Pirogovskaya str., 119435 Moscow, Russia.
Oleg M PanasenkoLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, 1a Malaya Pirogovskaya str., 119435 Moscow, Russia.ORCID 0000-0001-5245-2285 Elena V MikhalchikLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, 1a Malaya Pirogovskaya str., 119435 Moscow, Russia.
Funding
Belarusian Republican Foundation for Basic Research No. B23RNF-093Russian Science Foundation No. 23-45-10026
6 · The paper itselfAbstract
Fucoidan is of considerable interest for the development of drug carriers. The inclusion of fucoidan allows calcium carbonate microparticles in the form of vaterite to acquire new properties, enabling their use in the immobilization of protein preparations. In this work, we investigated the properties of hybrid vaterite microparticles with fucoidan from
Indexed as
Calcium CarbonateDrug CarriersLactoferrinPolysaccharidesAnimalsAnti-Bacterial AgentsAnticoagulantsBacillus subtilisGoatsHumansParticle SizeAnti-Bacterial AgentsAnticoagulantsCalcium CarbonateDrug CarriersfucoidanLactoferrinPolysaccharidesantibacterial propertiesanticoagulant propertiesB. subtilisfucoidanlactoferrinmucoadhesive propertiespH sensitivityprolonged releasevaterite
Identifiers
PMID41295396
PMCPMC12653817
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390